1.
Flach J, Jann J-C, Knaflic A, Riabov V, Streuer A, Altrock E, Xu Q, Schmitt N, Obländer J, Nowak V, Danner J, Mehralivand A, Hofmann F, Palme I, Jawhar A, Wuchter P, Metzgeroth G, Nolte F, Hofmann W-K, Nowak D. Replication stress signaling is a therapeutic target in myelodysplastic syndromes with splicing factor mutations. Haematologica 2020;106(11):2906-2917; https://doi.org/10.3324/haematol.2020.254193.